Rehabilitation of Single Aesthetic Areas Using Narrow Diameter Implants
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jul 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the use of narrow diameter dental implants to help patients who have lost a single tooth in the front part of their mouth, especially those with less bone thickness or limited space. The goal is to find a simpler and less invasive way to restore these patients' smiles without needing more complicated treatments. While there is not much research on this topic, the trial aims to gather important information about how effective these narrow implants can be.
To participate in this study, you should be an adult over 18 years old, a non-smoker or someone who smokes only a few cigarettes a day, and generally healthy (classified as ASA I or II, which means you have no major health issues). You'll need to sign a consent form to show you understand the study. If you have certain medical conditions, such as severe diseases or uncontrolled diabetes, or if you're pregnant or breastfeeding, you may not be eligible to join. Participants will receive careful follow-up throughout the study to monitor their progress and ensure their safety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who have undergone implant surgery to perform implant rehabilitation of single edentulism in the anterior region to insert a reduced diameter implant;
- • ASA I and ASA II patients;
- • Age \> 18yr;
- • Non-smokers or smokers ≤ 5 cig/day;
- • Achievement of FMPS and FMBS ≤ 15%;
- • Signing of the written informed consent to participate in the study.
- Exclusion Criteria:
- • Severe general medical pathologies;
- • Immunodeficiency states;
- • Radiotherapy in the head and neck region;
- • Uncontrolled diabetes or hypertension;
- • Smokers \>5 cigs/day;
- • Impossibility to carry out homogeneous and continuous follow-up;
- • Documented allergy to the biomaterials used;
- • Pregnancy or breastfeeding;
- • Inability to provide written informed consent.
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, Roma, Italy
Patients applied
Trial Officials
Paolo Francesco Manicone
Principal Investigator
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported